News

Your guide to catching our Washington University Cardiovascular faculty and fellows at the AHA Scientific Sessions in Chicago!

Justin Chen, MD, First Year Cardiology Fellow, First Author along with Anubha Agarwal, MD, MSc, Assistant Professor of Medicine, Co-Director, Program in Global Cardiovascular Health, WashU Medicine Cardiovascular Division, Senior Author, have published in Circulation: Cardiovascular Quality and Outcomes.

I am pleased to announce that Dr. Marc Sintek, Associate Professor of Medicine and Director of the Interventional Cardiology Fellowship, has been appointed as the next Director of the BJH Cardiac Catheterization Laboratory. Dr. Sintek has served as Associate Director of the Cath Lab since 2023 and will take the reins from Dr. Jas Singh

In a new paper published in JACC: Advances, Drs. Anubha Agarwal, Mark Huffman, and Global Health Clinical Research Coordinator Adam Hively, MPH examine the history of polypill trials. The paper, titled “More Than a Decade of Atherosclerotic Cardiovascular Disease Polypill Trials: Lessons for Heart Failure Polypills” marks the first publication for Hively, as the Global Health team within the WashU cardiovascular division continues research into this lifesaving therapy.

Wearables like Apple Watches, Fitbits, Oura Rings, WHOOP, Garmin, and other fitness trackers generally work by continuously monitoring your body’s signals and using machine learning algorithms to identify changes from your normal levels. Most of these devices rely on photoplethysmography (PPG), a non-invasive optical technique that measures blood flow by using light and sensors to detect changes in blood volume at the skin’s surface, Thomas Maddox, MD, a professor of medicine at the Washington University School of Medicine in St. Louis and the executive director of the Healthcare Innovation Lab at BJC HealthCare, told Health.

A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy — similar to that approved by the Food and Drug Administration (FDA) to treat inflammatory conditions such as arthritis — also may be an effective treatment strategy for heart failure. The study is published Oct. 23 in the journal Nature.

Dr. Nathan Frogge has joined the Department of Medicine in the Cardiovascular Division as an Assistant Professor in October 2024. He serves as faculty in the Interventional and Structural Cardiology Section and our West County Clinic, and as Director of Clinical Outreach and Expansion.